Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06236477 · ClinicalTrials.gov registry record · Phase 1
Decreasing Emergence Delirium With Personalized Music
A Phase 1 study of Emergence Delirium, sponsored by Washington University School of Medicine.
- Active
- Registry status
- Phase 1
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT06236477: Active Phase 1 study of Emergence Delirium, sponsored by Washington University School of Medicine.
NCT06236477 is a Phase 1 study of Emergence Delirium that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 160 participants, above the 97-participant average among 3 other Emergence Delirium trials with a reported enrollment target (65% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06236477, a Phase 1 study of Emergence Delirium, is active but no longer recruiting, sponsored by Washington University School of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective randomized controlled trial in children 3-9 years of age undergoing myringotomies at Washington University in St. Louis to assess the impact of perioperative personalized music on the incidence of emergence agitation.
Primary Outcome
Assessment scale for emergence delirium.Range 0-20, higher score indicates a worse outcome
Conditions Studied
Interventions
- BEHAVIORAL Personalized Music
- BEHAVIORAL No Music
Study Locations (1)
Missouri
- Washington University in St. Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2024-01-26 |
| Est. Completion | 2026-03-28 |
| Phase | Phase 1 |
What the registry record for NCT06236477 still lists
NCT06236477 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 97-participant average among 3 other Emergence Delirium trials with a reported enrollment target (65% higher).
The record links to 1 condition, with Emergence Delirium appearing as the primary indexed condition, and to 2 interventions - of which Personalized Music is the first listed.
NCT06236477 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06236477 about?
NCT06236477 is a clinical study titled "Decreasing Emergence Delirium With Personalized Music". This is a prospective randomized controlled trial in children 3-9 years of age undergoing myringotomies at Washington University in St. Louis to assess the impact of perioperative personalized music on the incidence of emergence agitation.
What is the current status of trial NCT06236477?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 160 participants. The study started on 2024-01-26. Estimated completion is 2026-03-28.
What conditions does trial NCT06236477 study?
This clinical trial studies the following conditions: Emergence Delirium.
What interventions are being tested in trial NCT06236477?
The interventions under investigation include: Personalized Music (BEHAVIORAL), No Music (BEHAVIORAL).
Who is sponsoring clinical trial NCT06236477?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06236477 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emergence Delirium
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI